Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany

被引：0
|
作者：
Ja Bin Hong
Kristin Sophie Lange
Mira Fitzek
Lucas Hendrik Overeem
Paul Triller
Anke Siebert
Uwe Reuter
Bianca Raffaelli
机构：
[1] Charité-Universitätsmedizin Berlin,Department of Neurology
[2] Universitätsmedizin Greifswald,undefined
[3] Clinician Scientist Program,undefined
[4] Berlin Institute of Health (BIH) at Charité,undefined
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Migraine; Preventive treatment; Monoclonal antibodies; Calcitonin gene-related peptide; Erenumab; Insurance coverage; Health policy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany
    Hong, Ja Bin
    Lange, Kristin Sophie
    Fitzek, Mira
    Overeem, Lucas Hendrik
    Triller, Paul
    Siebert, Anke
    Reuter, Uwe
    Raffaelli, Bianca
    [J]. JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [2] Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine
    Robblee, Jennifer
    Devick, Katrina L.
    Mendez, Natasha
    Potter, Jamie
    Slonaker, Jennifer
    Starling, Amaal J.
    [J]. HEADACHE, 2020, 60 (09): : 2014 - 2025
  • [3] Erenumab for Migraine Treatment - First Real World Data from Germany
    Naegel, Steffen
    Scheffler, Armin
    Wurthmann, Sebastian F.
    Holle, Dagny
    [J]. CEPHALALGIA, 2019, 39 (1_SUPPL) : 409 - 409
  • [4] Effectiveness and safety of erenumab in chronic migraine: A Croatian real-world experience
    Mahovic, Darija
    Bracic, Matea
    Jakus, Lukrecija
    Cvetkovic, Vlasta Vukovic
    Krpan, Marina
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 214
  • [5] Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
    Alsaadi, Taoufik
    Noori, Suzan
    Varakian, Razmig
    Youssef, Saly
    Almadani, AbuBaker
    [J]. BMC NEUROLOGY, 2022, 22 (01)
  • [6] Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
    Taoufik Alsaadi
    Suzan Noori
    Razmig Varakian
    Saly Youssef
    AbuBaker Almadani
    [J]. BMC Neurology, 22
  • [7] Real-world data on erenumab interruption in migraine patients in Germany: the SPECTRE study
    Gaul, Charly
    Goebel, Hartmut
    Koch, Mirja
    Weiss, Cordula
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 232 - 233
  • [8] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    [J]. HEADACHE, 2022, 62 (01): : 78 - 88
  • [9] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    [J]. HELIYON, 2024, 10 (04)
  • [10] Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany
    Gaul, Charly
    Koch, Mirja
    Weiss, Cordula
    [J]. NEUROLOGY, 2023, 100 (17)
12345